EverHint – EMA 10/30 Crossover, SMA 20/50 Crossover, EMA 10 + Price + MACD – Top 36 Buy and Top 10 Sell Signals for Jun 24, 2026
Market Context
The mixed close across major indices on June 24, 2026 reflects a market in a mild consolidation phase rather than a decisive trending environment. The Dow's modest outperformance relative to the Nasdaq suggests rotation away from growth and technology names toward more value-oriented and defensive sectors — a dynamic that can create false or delayed crossover signals in momentum-heavy strategies like EMA 10/30 and MACD-based systems. When indices diverge like this, trend-following signals tend to be noisier, and traders should weight confirmation across multiple timeframes before acting.
The VIX sitting at 19.51 places volatility in a moderate zone — elevated enough to produce meaningful intraday swings, but not so extreme as to invalidate technical setups outright. For EMA and SMA crossover strategies, this level of volatility can cause whipsawing around signal thresholds, particularly in shorter-term crossovers like EMA 10/30. Traders should expect slightly wider price ranges around entry points and consider adjusting stop placements accordingly to avoid being shaken out of otherwise valid setups.
The emergence of Healthcare as the top sector for signals this session aligns well with the defensive rotation implied by the Dow's relative strength. In periods of moderate uncertainty — as reflected by a VIX near 20 and flat-to-negative broader market performance — capital tends to flow into defensive sectors, which can sustain cleaner, more reliable trend signals. This makes Healthcare-focused crossover setups potentially more actionable than those in higher-beta sectors, where the current volatility environment introduces greater signal noise.
EMA 10/30 Crossover
Detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30), generating both buy and sell signals. Uses two EMAs instead of EMA + SMA, making it more responsive to price changes and better suited for capturing short-to-medium term momentum shifts.
Entry Criteria:
- Buy: EMA10 crosses above EMA30
- Sell: EMA10 crosses below EMA30
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 1-4 weeks | Risk level: Medium
🟢 Buy Signals (15 of 37)
Ranked by RSI (lower RSI for buy signals = more oversold)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | AWK | American Water Works C... | Utilities | $129.64 | $25.3B |
| 2 | BKH | Black Hills Corporation | Utilities | $74.56 | $5.7B |
| 3 | BLD | TopBuild Corp. | Industrials | $415.68 | $11.7B |
| 4 | CGON | CG Oncology, Inc. Comm... | Healthcare | $68.72 | $6.1B |
| 5 | CLH | Clean Harbors, Inc. | Industrials | $298.79 | $15.8B |
| 6 | DD | DuPont de Nemours, Inc. | Basic Materials | $137.82 | $18.6B |
| 7 | DNTH | Dianthus Therapeutics,... | Healthcare | $90.80 | $3.8B |
| 8 | DUK | Duke Energy Corporation | Utilities | $126.53 | $98.6B |
| 9 | EG | Everest Re Group, Ltd. | Financial Services | $345.74 | $13.7B |
| 10 | ELS | Equity LifeStyle Prope... | Real Estate | $63.30 | $12.3B |
| 11 | ESNT | Essent Group Ltd. | Financial Services | $61.70 | $5.7B |
| 12 | EZPW | EZCORP, Inc. | Financial Services | $32.43 | $1.9B |
| 13 | FERG | Ferguson plc | Industrials | $236.56 | $45.9B |
| 14 | GATX | GATX Corporation | Industrials | $179.45 | $6.4B |
| 15 | GRAL | GRAIL, Inc. | Healthcare | $64.58 | $2.8B |
🔴 Sell Signals (5 of 24)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | ARES | Ares Management Corpor... | Financial Services | $113.92 | $37.4B |
| 2 | ASAN | Asana, Inc. | Technology | $6.65 | $1.6B |
| 3 | CI | Cigna Corporation | Healthcare | $279.46 | $73.9B |
| 4 | COKE | Coca-Cola Consolidated... | Consumer Defensive | $177.54 | $13.9B |
| 5 | CRWV | CoreWeave, Inc. Class ... | Technology | $100.88 | $55.0B |
SMA 20/50 Crossover
Detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50). Uses two SMAs, making it more stable and less prone to false signals compared to EMA-based strategies. Well-suited for identifying medium-term trend changes with higher reliability.
Entry Criteria:
- Buy: SMA20 crosses above SMA50
- Sell: SMA20 crosses below SMA50
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 2-6 weeks | Risk level: Medium
🟢 Buy Signals (6 of 6)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | HROW | Harrow Health, Inc. | Healthcare | $42.68 | $1.6B |
| 2 | IBN | ICICI Bank Limited | Financial Services | $29.00 | $104.0B |
| 3 | MIRM | Mirum Pharmaceuticals,... | Healthcare | $114.97 | $5.8B |
| 4 | NTLA | Intellia Therapeutics,... | Healthcare | $15.50 | $1.7B |
| 5 | ORKA | Oruka Therapeutics, Inc. | Healthcare | $82.09 | $3.1B |
| 6 | RCUS | Arcus Biosciences, Inc. | Healthcare | $28.80 | $2.9B |
🔴 Sell Signals (5 of 15)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | ADTN | ADTRAN Holdings, Inc. | Technology | $13.96 | $1.1B |
| 2 | AESI | Atlas Energy Solutions... | Energy | $15.78 | $2.0B |
| 3 | AMBA | Ambarella, Inc. | Technology | $62.99 | $2.8B |
| 4 | CRUS | Cirrus Logic, Inc. | Technology | $157.67 | $8.0B |
| 5 | EGP | EastGroup Properties, ... | Real Estate | $203.55 | $10.9B |
EMA 10 + Price + MACD
Experimental strategy combining price crossing above EMA10 from below with MACD Line crossing above Signal Line from below. Both conditions must occur on the same day for a signal, providing double confirmation and higher-quality setups.
Entry Criteria:
- Buy: Price > EMA10 AND MACD line crosses above signal line
- Sell: Price < EMA10 AND MACD line crosses below signal line
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh signal: All conditions met on today's close
Holding period: 1-3 weeks | Risk level: Medium-High
🟢 Buy Signals (15 of 21)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | MCap |
|---|---|---|---|---|---|
| 1 | AGCO | AGCO Corporation | Industrials | $114.58 | $8.3B |
| 2 | BC | Brunswick Corporation | Consumer Cyclical | $84.85 | $5.5B |
| 3 | CWST | Casella Waste Systems,... | Industrials | $91.24 | $5.7B |
| 4 | DD | DuPont de Nemours, Inc. | Basic Materials | $137.82 | $18.6B |
| 5 | DHR | Danaher Corporation | Healthcare | $188.87 | $133.7B |
| 6 | ERIE | Erie Indemnity Company | Financial Services | $229.53 | $10.6B |
| 7 | LLYVK | Liberty Live Group | Communication Services | $99.50 | $9.2B |
| 8 | MBC | MasterBrand, Inc. | Consumer Cyclical | $9.34 | $1.2B |
| 9 | MELI | MercadoLibre, Inc. | Consumer Cyclical | $1659.57 | $84.1B |
| 10 | POST | Post Holdings, Inc. | Consumer Defensive | $90.84 | $4.1B |
| 11 | QTWO | Q2 Holdings, Inc. | Technology | $45.03 | $2.8B |
| 12 | RGEN | Repligen Corporation | Healthcare | $138.40 | $7.8B |
| 13 | RUN | Sunrun Inc. | Technology | $14.42 | $3.4B |
| 14 | SHC | Sotera Health Company | Healthcare | $16.69 | $4.8B |
| 15 | SHOP | Shopify Inc. | Technology | $114.17 | $148.2B |
Field Notes
Sector concentration: Healthcare (25), Technology (20), Financial Services (11)
Data coverage: 0.0% insider, 0.0% congressional, 0.0% earnings, 7.8% news
Vlad's Take
Today's signals: Strong sector concentration in Healthcare (25 signals) suggests sector-specific rotation.
Trading tips for this strategy:
- Entry timing: Enter on pullback after crossover or at crossover close price
- Position sizing: Start with 2-3% of portfolio per signal (swing trade size)
- Stop loss: Below recent swing low for buys, above recent swing high for sells
- Take profit: 5-10% target for swings, or trail stop at EMA10
- Time stop: Exit if crossover reverses within 1-2 weeks (failed signal)
Risk warning: EMA crossovers generate more signals but higher whipsaw risk in ranging markets. Use with trend filter (price vs SMA200)
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 If this added value to your research, consider liking, sharing, or subscribing. It genuinely helps.